Growth disturbance associated with Turner syndrome.
For this indication, competent medicine agencies globally authorize below treatments:
For: Newborns Infants Children Adolescents
Subcutaneous
1.4 - 1.4 mg per m² of body surface area (BSA)
From 1.4 To 1.4 mg per m² of body surface area (BSA) once every day
A dose of 1.4 mg/m² body surface area per day is recommended.
The injection should be given subcutaneously and the site varied to prevent lipoatrophy.
For: Newborns Infants Children Adolescents
Subcutaneous
45 - 50 ug per kg of body weight
From 45 To 50 ug per kg of body weight once every day
A dose of 0.045-0.050 mg/kg body weight per day is recommended.
The injection should be given subcutaneously and the site varied to prevent lipoatrophy.